SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
哈哈哈哈
Lv1
80 积分
2023-10-15 加入
最近求助
最近应助
互助留言
Ozanimod in relapsing multiple sclerosis: Pooled safety results from the clinical development program
1天前
已完结
Ozanimod: A Review in Ulcerative Colitis
2天前
已完结
Matching-adjusted indirect treatment comparison of ozanimod versus teriflunomide for relapsing multiple sclerosis
2天前
已完结
Ozanimod as Induction and Maintenance Therapy for Ulcerative Colitis
2天前
已完结
Ozanimod (RPC1063) is a potent sphingosine‐1‐phosphate receptor‐1 (S1P1) and receptor‐5 (S1P5) agonist with autoimmune disease‐modifying activity
10天前
已完结
P038 Ozanimod First-Dose Cardiac Effects in Patients with Moderately to Severely Active Ulcerative Colitis and Relapsing Multiple Sclerosis
12天前
已完结
Efficacy and safety of ozanimod in multiple sclerosis: Dose-blinded extension of a randomized phase II study
12天前
已完结
Long-term safety and efficacy of ozanimod in relapsing multiple sclerosis: Up to 5 years of follow-up in the DAYBREAK open-label extension trial
12天前
已完结
Safety and efficacy of ozanimod versus interferon beta-1a in relapsing multiple sclerosis (SUNBEAM): a multicentre, randomised, minimum 12-month, phase 3 trial
12天前
已完结
Multiple sclerosis – a review
12天前
已完结
没有进行任何应助
没有进行任何互助留言
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论